How Analysts Feel About Transenterix Inc (NYSEAMERICAN:TRXC) After Decrease in Sellers?

October 13, 2018 - By Ellis Scott

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Logo

Investors sentiment increased to 2.15 in 2018 Q2. Its up 0.51, from 1.64 in 2018Q1. It increased, as 15 investors sold TransEnterix, Inc. shares while 18 reduced holdings. 47 funds opened positions while 24 raised stakes. 59.38 million shares or 18.11% more from 50.28 million shares in 2018Q1 were reported.
The Nebraska-based Ameritas Investment has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). California-based Jasper Ridge Prns L P has invested 0.02% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Pittenger Anderson Inc reported 0% stake. Northwestern Mutual Wealth Company invested in 0% or 1,138 shares. Tradewinds Management Limited Liability holds 200 shares. Dimensional Fund Advsrs L P reported 87,456 shares. Jfs Wealth Advisors Limited has 500 shares for 0% of their portfolio. The Ontario – Canada-based Fincl Bank Of Montreal Can has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Lifeplan Group Incorporated invested 0% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Tiaa Cref Mgmt Limited Liability Com reported 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Interest Group reported 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Jpmorgan Chase & holds 0.01% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 6.98 million shares. Invesco holds 0% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 41,872 shares. 50,810 were accumulated by Raymond James Finance Svcs Advsr Inc. Moreover, Eam Ltd Liability Com has 0.17% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 245,801 shares.

Since June 1, 2018, it had 0 insider purchases, and 6 sales for $7.64 million activity. $1.78M worth of stock was sold by Pope Todd on Monday, June 25. SLATTERY JOSEPH P had sold 699,486 shares worth $3.78 million on Monday, June 25.

The stock of Transenterix Inc (NYSEAMERICAN:TRXC) registered a decrease of 4.04% in short interest. TRXC’s total short interest was 31.38 million shares in October as published by FINRA. Its down 4.04% from 32.71M shares, reported previously. With 5.24M shares average volume, it will take short sellers 6 days to cover their TRXC’s short positions.

The stock decreased 1.85% or $0.09 during the last trading session, reaching $4.78. About 6.91M shares traded or 6.98% up from the average. TransEnterix, Inc. (NYSEAMERICAN:TRXC) has risen 330.95% since October 13, 2017 and is uptrending. It has outperformed by 315.33% the S&P500.

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems. The company has market cap of $1.00 billion. The firm offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It currently has negative earnings. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.

Another recent and important TransEnterix, Inc. (NYSEAMERICAN:TRXC) news was published by Finance.Yahoo.com which published an article titled: “TransEnterix’s MST Medical Buyout to Boost Senhance Platform” on September 24, 2018.

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>